nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ANXA1—kidney cancer	0.246	0.683	CbGaD
Dexamethasone—NR0B1—Vincristine—kidney cancer	0.0542	0.127	CbGbCtD
Dexamethasone—CYP1A1—kidney cancer	0.0528	0.147	CbGaD
Dexamethasone—PTGS2—kidney cancer	0.033	0.0918	CbGaD
Dexamethasone—NOS2—Doxorubicin—kidney cancer	0.0284	0.0664	CbGbCtD
Dexamethasone—ABCB1—kidney cancer	0.0281	0.0781	CbGaD
Dexamethasone—CYP1B1—Erlotinib—kidney cancer	0.0137	0.0321	CbGbCtD
Dexamethasone—CYP3A7—Temsirolimus—kidney cancer	0.0128	0.0301	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0128	0.0301	CbGbCtD
Dexamethasone—CYP1B1—Paclitaxel—kidney cancer	0.0125	0.0294	CbGbCtD
Dexamethasone—ABCB11—Paclitaxel—kidney cancer	0.0125	0.0294	CbGbCtD
Dexamethasone—ABCB11—Vinblastine—kidney cancer	0.011	0.0258	CbGbCtD
Dexamethasone—ABCB11—Vincristine—kidney cancer	0.0108	0.0253	CbGbCtD
Dexamethasone—CYP19A1—Paclitaxel—kidney cancer	0.0102	0.0238	CbGbCtD
Dexamethasone—CYP3A5—Temsirolimus—kidney cancer	0.00963	0.0225	CbGbCtD
Dexamethasone—ABCG2—Pazopanib—kidney cancer	0.00913	0.0214	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—kidney cancer	0.00835	0.0196	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—kidney cancer	0.00676	0.0158	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—kidney cancer	0.00676	0.0158	CbGbCtD
Dexamethasone—ABCC2—Paclitaxel—kidney cancer	0.0066	0.0154	CbGbCtD
Dexamethasone—ABCG2—Erlotinib—kidney cancer	0.00652	0.0153	CbGbCtD
Dexamethasone—ABCB1—Temsirolimus—kidney cancer	0.00627	0.0147	CbGbCtD
Dexamethasone—CYP1A1—Erlotinib—kidney cancer	0.00602	0.0141	CbGbCtD
Dexamethasone—ABCG2—Paclitaxel—kidney cancer	0.00597	0.014	CbGbCtD
Dexamethasone—CYP2D6—Temsirolimus—kidney cancer	0.00591	0.0138	CbGbCtD
Dexamethasone—ABCC2—Sorafenib—kidney cancer	0.00586	0.0137	CbGbCtD
Dexamethasone—ABCC2—Vinblastine—kidney cancer	0.00579	0.0135	CbGbCtD
Dexamethasone—ABCC2—Vincristine—kidney cancer	0.00569	0.0133	CbGbCtD
Dexamethasone—CYP3A4—Everolimus—kidney cancer	0.00556	0.013	CbGbCtD
Dexamethasone—ABCG2—Sorafenib—kidney cancer	0.0053	0.0124	CbGbCtD
Dexamethasone—ABCG2—Vincristine—kidney cancer	0.00514	0.012	CbGbCtD
Dexamethasone—CYP2C8—Pazopanib—kidney cancer	0.00487	0.0114	CbGbCtD
Dexamethasone—ABCC2—Sunitinib—kidney cancer	0.00475	0.0111	CbGbCtD
Dexamethasone—NR3C2—collecting duct of renal tubule—kidney cancer	0.00458	0.108	CbGeAlD
Dexamethasone—CYP3A7—Paclitaxel—kidney cancer	0.00441	0.0103	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00441	0.0103	CbGbCtD
Dexamethasone—ABCG2—Sunitinib—kidney cancer	0.00429	0.01	CbGbCtD
Dexamethasone—PLA2G1B—nephron—kidney cancer	0.00412	0.0971	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00391	0.00916	CbGbCtD
Dexamethasone—CYP3A7—Sorafenib—kidney cancer	0.00391	0.00916	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—kidney cancer	0.0038	0.00889	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0038	0.00889	CbGbCtD
Dexamethasone—CYP3A4—Temsirolimus—kidney cancer	0.00376	0.00879	CbGbCtD
Dexamethasone—CYP2B6—Sorafenib—kidney cancer	0.00373	0.00872	CbGbCtD
Dexamethasone—CYP3A5—Erlotinib—kidney cancer	0.00361	0.00845	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—kidney cancer	0.00356	0.00832	CbGbCtD
Dexamethasone—CYP2C9—Capecitabine—kidney cancer	0.00354	0.00828	CbGbCtD
Dexamethasone—CYP2C8—Erlotinib—kidney cancer	0.00347	0.00813	CbGbCtD
Dexamethasone—CYP3A5—Paclitaxel—kidney cancer	0.00331	0.00774	CbGbCtD
Dexamethasone—ABCB1—Pazopanib—kidney cancer	0.00329	0.00771	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—kidney cancer	0.00322	0.00753	CbGbCtD
Dexamethasone—CYP2C8—Paclitaxel—kidney cancer	0.00318	0.00744	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00317	0.00742	CbGbCtD
Dexamethasone—CYP3A7—Sunitinib—kidney cancer	0.00317	0.00742	CbGbCtD
Dexamethasone—CYP2D6—Pazopanib—kidney cancer	0.0031	0.00726	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—kidney cancer	0.00301	0.00705	CbGbCtD
Dexamethasone—CYP3A5—Sorafenib—kidney cancer	0.00294	0.00687	CbGbCtD
Dexamethasone—CYP3A5—Vincristine—kidney cancer	0.00285	0.00667	CbGbCtD
Dexamethasone—CYP2C8—Sorafenib—kidney cancer	0.00282	0.00661	CbGbCtD
Dexamethasone—ABCB1—Gemcitabine—kidney cancer	0.00238	0.00557	CbGbCtD
Dexamethasone—CYP3A5—Sunitinib—kidney cancer	0.00238	0.00557	CbGbCtD
Dexamethasone—CYP2C19—Sorafenib—kidney cancer	0.00237	0.00554	CbGbCtD
Dexamethasone—ABCB1—Erlotinib—kidney cancer	0.00235	0.0055	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—kidney cancer	0.00226	0.00529	CbGbCtD
Dexamethasone—CYP2C9—Paclitaxel—kidney cancer	0.00222	0.00519	CbGbCtD
Dexamethasone—CYP2D6—Erlotinib—kidney cancer	0.00221	0.00518	CbGbCtD
Dexamethasone—ABCB1—Paclitaxel—kidney cancer	0.00215	0.00503	CbGbCtD
Dexamethasone—NR3C2—nephron—kidney cancer	0.00204	0.0481	CbGeAlD
Dexamethasone—CYP3A4—Pazopanib—kidney cancer	0.00197	0.00462	CbGbCtD
Dexamethasone—CYP2C9—Sorafenib—kidney cancer	0.00197	0.00461	CbGbCtD
Dexamethasone—ABCB1—Sorafenib—kidney cancer	0.00191	0.00447	CbGbCtD
Dexamethasone—ABCB1—Vinblastine—kidney cancer	0.00189	0.00442	CbGbCtD
Dexamethasone—ABCB1—Vincristine—kidney cancer	0.00185	0.00434	CbGbCtD
Dexamethasone—CYP2D6—Sorafenib—kidney cancer	0.0018	0.00421	CbGbCtD
Dexamethasone—CYP2D6—Vinblastine—kidney cancer	0.00178	0.00416	CbGbCtD
Dexamethasone—ABCB1—Sunitinib—kidney cancer	0.00155	0.00362	CbGbCtD
Dexamethasone—CYP3A4—Erlotinib—kidney cancer	0.00141	0.0033	CbGbCtD
Dexamethasone—CYP3A4—Paclitaxel—kidney cancer	0.00129	0.00302	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—kidney cancer	0.00116	0.00271	CbGbCtD
Dexamethasone—CYP3A4—Sorafenib—kidney cancer	0.00114	0.00268	CbGbCtD
Dexamethasone—CYP3A4—Vinblastine—kidney cancer	0.00113	0.00265	CbGbCtD
Dexamethasone—CYP2C19—urine—kidney cancer	0.00112	0.0265	CbGeAlD
Dexamethasone—CYP3A4—Vincristine—kidney cancer	0.00111	0.0026	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—kidney cancer	0.00109	0.00256	CbGbCtD
Dexamethasone—NR0B1—gonad—kidney cancer	0.00102	0.024	CbGeAlD
Dexamethasone—CYP4A11—renal system—kidney cancer	0.000975	0.023	CbGeAlD
Dexamethasone—PTGS2—nephron—kidney cancer	0.000946	0.0223	CbGeAlD
Dexamethasone—CYP4A11—kidney—kidney cancer	0.000942	0.0222	CbGeAlD
Dexamethasone—CYP3A4—Sunitinib—kidney cancer	0.000928	0.00217	CbGbCtD
Dexamethasone—CYP4A11—cortex of kidney—kidney cancer	0.000918	0.0216	CbGeAlD
Dexamethasone—NR3C1—urine—kidney cancer	0.000877	0.0207	CbGeAlD
Dexamethasone—CYP2C9—urine—kidney cancer	0.00087	0.0205	CbGeAlD
Dexamethasone—CYP2E1—urine—kidney cancer	0.000824	0.0194	CbGeAlD
Dexamethasone—PLA2G1B—renal system—kidney cancer	0.000808	0.019	CbGeAlD
Dexamethasone—PLA2G1B—kidney—kidney cancer	0.000781	0.0184	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—kidney cancer	0.000695	0.00163	CbGbCtD
Dexamethasone—Amcinonide—ANXA1—kidney cancer	0.000681	0.417	CrCbGaD
Dexamethasone—ANXA1—nephron tubule—kidney cancer	0.00068	0.016	CbGeAlD
Dexamethasone—CYP3A4—urine—kidney cancer	0.000663	0.0156	CbGeAlD
Dexamethasone—CYP2D6—urine—kidney cancer	0.000653	0.0154	CbGeAlD
Dexamethasone—ANXA1—renal system—kidney cancer	0.000618	0.0146	CbGeAlD
Dexamethasone—CYP17A1—nephron tubule—kidney cancer	0.000609	0.0144	CbGeAlD
Dexamethasone—ANXA1—kidney—kidney cancer	0.000597	0.0141	CbGeAlD
Dexamethasone—ANXA1—cortex of kidney—kidney cancer	0.000582	0.0137	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000575	0.0136	CbGeAlD
Dexamethasone—ANXA1—gonad—kidney cancer	0.000554	0.0131	CbGeAlD
Dexamethasone—CYP17A1—renal system—kidney cancer	0.000554	0.0131	CbGeAlD
Dexamethasone—ANXA1—cardiac atrium—kidney cancer	0.000553	0.013	CbGeAlD
Dexamethasone—CYP17A1—kidney—kidney cancer	0.000535	0.0126	CbGeAlD
Dexamethasone—CYP17A1—cortex of kidney—kidney cancer	0.000521	0.0123	CbGeAlD
Dexamethasone—CYP17A1—gonad—kidney cancer	0.000496	0.0117	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000492	0.0116	CbGeAlD
Dexamethasone—CYP11A1—gonad—kidney cancer	0.000462	0.0109	CbGeAlD
Dexamethasone—NR3C2—nephron tubule—kidney cancer	0.00044	0.0104	CbGeAlD
Dexamethasone—NR3C2—renal system—kidney cancer	0.0004	0.00943	CbGeAlD
Dexamethasone—NR3C2—kidney—kidney cancer	0.000387	0.00912	CbGeAlD
Dexamethasone—NR3C2—cortex of kidney—kidney cancer	0.000377	0.00888	CbGeAlD
Dexamethasone—NR3C2—cardiac atrium—kidney cancer	0.000358	0.00845	CbGeAlD
Dexamethasone—ABCC2—nephron tubule—kidney cancer	0.000351	0.00829	CbGeAlD
Dexamethasone—CYP1B1—nephron tubule—kidney cancer	0.000344	0.00812	CbGeAlD
Dexamethasone—SLCO1A2—renal system—kidney cancer	0.000343	0.00809	CbGeAlD
Dexamethasone—SLCO1A2—kidney—kidney cancer	0.000331	0.00782	CbGeAlD
Dexamethasone—ABCC2—renal system—kidney cancer	0.000319	0.00753	CbGeAlD
Dexamethasone—CYP1B1—renal system—kidney cancer	0.000313	0.00738	CbGeAlD
Dexamethasone—ABCC2—kidney—kidney cancer	0.000309	0.00728	CbGeAlD
Dexamethasone—CYP1B1—kidney—kidney cancer	0.000302	0.00713	CbGeAlD
Dexamethasone—ABCC2—cortex of kidney—kidney cancer	0.000301	0.00709	CbGeAlD
Dexamethasone—CYP19A1—gonad—kidney cancer	0.0003	0.00708	CbGeAlD
Dexamethasone—CYP1B1—cortex of kidney—kidney cancer	0.000295	0.00695	CbGeAlD
Dexamethasone—Hydrocortisone—ANXA1—kidney cancer	0.000287	0.176	CrCbGaD
Dexamethasone—CYP1B1—gonad—kidney cancer	0.000281	0.00662	CbGeAlD
Dexamethasone—ABCG2—nephron tubule—kidney cancer	0.000256	0.00604	CbGeAlD
Dexamethasone—CYP2C8—renal system—kidney cancer	0.00024	0.00565	CbGeAlD
Dexamethasone—CYP3A5—nephron tubule—kidney cancer	0.000238	0.00561	CbGeAlD
Dexamethasone—CYP2B6—nephron tubule—kidney cancer	0.000236	0.00558	CbGeAlD
Dexamethasone—NR3C1—nephron tubule—kidney cancer	0.000236	0.00557	CbGeAlD
Dexamethasone—CYP2C8—kidney—kidney cancer	0.000232	0.00546	CbGeAlD
Dexamethasone—CYP2E1—nephron tubule—kidney cancer	0.000222	0.00523	CbGeAlD
Dexamethasone—CYP1A1—renal system—kidney cancer	0.000221	0.00522	CbGeAlD
Dexamethasone—CYP3A5—renal system—kidney cancer	0.000216	0.0051	CbGeAlD
Dexamethasone—CYP2B6—renal system—kidney cancer	0.000215	0.00507	CbGeAlD
Dexamethasone—NR3C1—renal system—kidney cancer	0.000215	0.00506	CbGeAlD
Dexamethasone—CYP1A1—kidney—kidney cancer	0.000214	0.00504	CbGeAlD
Dexamethasone—CYP3A5—kidney—kidney cancer	0.000209	0.00493	CbGeAlD
Dexamethasone—CYP2B6—kidney—kidney cancer	0.000208	0.0049	CbGeAlD
Dexamethasone—NR3C1—kidney—kidney cancer	0.000207	0.00489	CbGeAlD
Dexamethasone—CYP3A5—cortex of kidney—kidney cancer	0.000204	0.0048	CbGeAlD
Dexamethasone—NR3C1—cortex of kidney—kidney cancer	0.000202	0.00476	CbGeAlD
Dexamethasone—CYP2E1—renal system—kidney cancer	0.000202	0.00476	CbGeAlD
Dexamethasone—CYP1A1—cardiac atrium—kidney cancer	0.000198	0.00467	CbGeAlD
Dexamethasone—CYP2E1—kidney—kidney cancer	0.000195	0.0046	CbGeAlD
Dexamethasone—CYP2B6—gonad—kidney cancer	0.000193	0.00454	CbGeAlD
Dexamethasone—NR3C1—gonad—kidney cancer	0.000192	0.00454	CbGeAlD
Dexamethasone—NR3C1—cardiac atrium—kidney cancer	0.000192	0.00453	CbGeAlD
Dexamethasone—CYP2E1—cortex of kidney—kidney cancer	0.00019	0.00448	CbGeAlD
Dexamethasone—PTGS2—renal system—kidney cancer	0.000186	0.00438	CbGeAlD
Dexamethasone—PTGS2—kidney—kidney cancer	0.00018	0.00423	CbGeAlD
Dexamethasone—CYP3A4—renal system—kidney cancer	0.000162	0.00383	CbGeAlD
Dexamethasone—CYP2D6—renal system—kidney cancer	0.00016	0.00377	CbGeAlD
Dexamethasone—CYP3A4—kidney—kidney cancer	0.000157	0.0037	CbGeAlD
Dexamethasone—CYP2D6—kidney—kidney cancer	0.000154	0.00364	CbGeAlD
Dexamethasone—Triamcinolone—BCHE—kidney cancer	0.000131	0.0802	CrCbGaD
Dexamethasone—ABCB1—nephron tubule—kidney cancer	0.000126	0.00298	CbGeAlD
Dexamethasone—Clobetasol propionate—CYP1A1—kidney cancer	0.000123	0.0752	CrCbGaD
Dexamethasone—ABCB1—renal system—kidney cancer	0.000115	0.00271	CbGeAlD
Dexamethasone—ABCB1—kidney—kidney cancer	0.000111	0.00262	CbGeAlD
Dexamethasone—ABCB1—cortex of kidney—kidney cancer	0.000108	0.00255	CbGeAlD
Dexamethasone—ABCB1—gonad—kidney cancer	0.000103	0.00243	CbGeAlD
Dexamethasone—Fluticasone furoate—ABCB1—kidney cancer	7.63e-05	0.0467	CrCbGaD
Dexamethasone—Methylprednisolone—ABCB1—kidney cancer	6.08e-05	0.0372	CrCbGaD
Dexamethasone—Triamcinolone—PTGS2—kidney cancer	6.03e-05	0.0369	CrCbGaD
Dexamethasone—Cardiac failure congestive—Doxorubicin—kidney cancer	5.57e-05	0.000552	CcSEcCtD
Dexamethasone—Infection—Gemcitabine—kidney cancer	5.57e-05	0.000552	CcSEcCtD
Dexamethasone—Dizziness—Vinblastine—kidney cancer	5.55e-05	0.00055	CcSEcCtD
Dexamethasone—Dizziness—Everolimus—kidney cancer	5.53e-05	0.000548	CcSEcCtD
Dexamethasone—Abdominal pain—Sunitinib—kidney cancer	5.52e-05	0.000547	CcSEcCtD
Dexamethasone—Body temperature increased—Sunitinib—kidney cancer	5.52e-05	0.000547	CcSEcCtD
Dexamethasone—Diarrhoea—Erlotinib—kidney cancer	5.52e-05	0.000547	CcSEcCtD
Dexamethasone—Hypotension—Vincristine—kidney cancer	5.52e-05	0.000547	CcSEcCtD
Dexamethasone—Bradycardia—Capecitabine—kidney cancer	5.52e-05	0.000547	CcSEcCtD
Dexamethasone—Nervous system disorder—Gemcitabine—kidney cancer	5.5e-05	0.000545	CcSEcCtD
Dexamethasone—Thrombocytopenia—Gemcitabine—kidney cancer	5.49e-05	0.000544	CcSEcCtD
Dexamethasone—Feeling abnormal—Dactinomycin—kidney cancer	5.45e-05	0.00054	CcSEcCtD
Dexamethasone—Haemoglobin—Capecitabine—kidney cancer	5.45e-05	0.00054	CcSEcCtD
Dexamethasone—Haemorrhage—Capecitabine—kidney cancer	5.42e-05	0.000537	CcSEcCtD
Dexamethasone—Hyperhidrosis—Gemcitabine—kidney cancer	5.42e-05	0.000537	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Dactinomycin—kidney cancer	5.41e-05	0.000536	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Vincristine—kidney cancer	5.38e-05	0.000533	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—kidney cancer	5.38e-05	0.000533	CcSEcCtD
Dexamethasone—Insomnia—Vincristine—kidney cancer	5.35e-05	0.00053	CcSEcCtD
Dexamethasone—Anorexia—Gemcitabine—kidney cancer	5.34e-05	0.000529	CcSEcCtD
Dexamethasone—Vomiting—Vinblastine—kidney cancer	5.34e-05	0.000529	CcSEcCtD
Dexamethasone—Dizziness—Erlotinib—kidney cancer	5.34e-05	0.000529	CcSEcCtD
Dexamethasone—Ill-defined disorder—Paclitaxel—kidney cancer	5.34e-05	0.000529	CcSEcCtD
Dexamethasone—Vomiting—Everolimus—kidney cancer	5.32e-05	0.000527	CcSEcCtD
Dexamethasone—Paraesthesia—Vincristine—kidney cancer	5.31e-05	0.000526	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—kidney cancer	5.29e-05	0.000524	CcSEcCtD
Dexamethasone—Rash—Everolimus—kidney cancer	5.27e-05	0.000523	CcSEcCtD
Dexamethasone—Dermatitis—Everolimus—kidney cancer	5.27e-05	0.000522	CcSEcCtD
Dexamethasone—Headache—Vinblastine—kidney cancer	5.26e-05	0.000521	CcSEcCtD
Dexamethasone—Angioedema—Paclitaxel—kidney cancer	5.26e-05	0.000521	CcSEcCtD
Dexamethasone—Headache—Everolimus—kidney cancer	5.24e-05	0.000519	CcSEcCtD
Dexamethasone—Hypotension—Gemcitabine—kidney cancer	5.24e-05	0.000519	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—kidney cancer	5.23e-05	0.000518	CcSEcCtD
Dexamethasone—Body temperature increased—Dactinomycin—kidney cancer	5.23e-05	0.000518	CcSEcCtD
Dexamethasone—Visual impairment—Capecitabine—kidney cancer	5.23e-05	0.000518	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—kidney cancer	5.22e-05	0.000517	CcSEcCtD
Dexamethasone—Asthenia—Sorafenib—kidney cancer	5.21e-05	0.000516	CcSEcCtD
Dexamethasone—Malaise—Paclitaxel—kidney cancer	5.19e-05	0.000514	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—kidney cancer	5.18e-05	0.000513	CcSEcCtD
Dexamethasone—Vertigo—Paclitaxel—kidney cancer	5.17e-05	0.000512	CcSEcCtD
Dexamethasone—Syncope—Paclitaxel—kidney cancer	5.16e-05	0.000511	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—kidney cancer	5.16e-05	0.000511	CcSEcCtD
Dexamethasone—Decreased appetite—Vincristine—kidney cancer	5.14e-05	0.000509	CcSEcCtD
Dexamethasone—Pruritus—Sorafenib—kidney cancer	5.14e-05	0.000509	CcSEcCtD
Dexamethasone—Vomiting—Erlotinib—kidney cancer	5.13e-05	0.000508	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	5.11e-05	0.000506	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Vincristine—kidney cancer	5.1e-05	0.000505	CcSEcCtD
Dexamethasone—Fatigue—Vincristine—kidney cancer	5.1e-05	0.000505	CcSEcCtD
Dexamethasone—Rash—Erlotinib—kidney cancer	5.09e-05	0.000504	CcSEcCtD
Dexamethasone—Dermatitis—Erlotinib—kidney cancer	5.08e-05	0.000504	CcSEcCtD
Dexamethasone—Insomnia—Gemcitabine—kidney cancer	5.07e-05	0.000502	CcSEcCtD
Dexamethasone—Eye disorder—Capecitabine—kidney cancer	5.07e-05	0.000502	CcSEcCtD
Dexamethasone—Headache—Erlotinib—kidney cancer	5.06e-05	0.000501	CcSEcCtD
Dexamethasone—Loss of consciousness—Paclitaxel—kidney cancer	5.06e-05	0.000501	CcSEcCtD
Dexamethasone—Pain—Vincristine—kidney cancer	5.05e-05	0.000501	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—kidney cancer	5.05e-05	0.000501	CcSEcCtD
Dexamethasone—Paraesthesia—Gemcitabine—kidney cancer	5.03e-05	0.000499	CcSEcCtD
Dexamethasone—Asthenia—Sunitinib—kidney cancer	5.01e-05	0.000497	CcSEcCtD
Dexamethasone—Nausea—Vinblastine—kidney cancer	4.99e-05	0.000494	CcSEcCtD
Dexamethasone—Convulsion—Paclitaxel—kidney cancer	4.98e-05	0.000494	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—kidney cancer	4.97e-05	0.000493	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—kidney cancer	4.97e-05	0.000493	CcSEcCtD
Dexamethasone—Nausea—Everolimus—kidney cancer	4.97e-05	0.000492	CcSEcCtD
Dexamethasone—Diarrhoea—Sorafenib—kidney cancer	4.97e-05	0.000492	CcSEcCtD
Dexamethasone—Hypertension—Paclitaxel—kidney cancer	4.97e-05	0.000492	CcSEcCtD
Dexamethasone—Pruritus—Sunitinib—kidney cancer	4.94e-05	0.00049	CcSEcCtD
Dexamethasone—Betamethasone—PTGS2—kidney cancer	4.94e-05	0.0303	CrCbGaD
Dexamethasone—Angiopathy—Capecitabine—kidney cancer	4.92e-05	0.000487	CcSEcCtD
Dexamethasone—Myalgia—Paclitaxel—kidney cancer	4.9e-05	0.000485	CcSEcCtD
Dexamethasone—Anxiety—Paclitaxel—kidney cancer	4.88e-05	0.000483	CcSEcCtD
Dexamethasone—Decreased appetite—Gemcitabine—kidney cancer	4.87e-05	0.000483	CcSEcCtD
Dexamethasone—Arrhythmia—Capecitabine—kidney cancer	4.84e-05	0.00048	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Gemcitabine—kidney cancer	4.84e-05	0.00048	CcSEcCtD
Dexamethasone—Discomfort—Paclitaxel—kidney cancer	4.84e-05	0.000479	CcSEcCtD
Dexamethasone—Fatigue—Gemcitabine—kidney cancer	4.83e-05	0.000479	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Vincristine—kidney cancer	4.83e-05	0.000479	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—kidney cancer	4.8e-05	0.000476	CcSEcCtD
Dexamethasone—Dizziness—Sorafenib—kidney cancer	4.8e-05	0.000476	CcSEcCtD
Dexamethasone—Pain—Gemcitabine—kidney cancer	4.79e-05	0.000475	CcSEcCtD
Dexamethasone—Nausea—Erlotinib—kidney cancer	4.79e-05	0.000475	CcSEcCtD
Dexamethasone—Alopecia—Capecitabine—kidney cancer	4.79e-05	0.000475	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—kidney cancer	4.79e-05	0.000474	CcSEcCtD
Dexamethasone—Diarrhoea—Sunitinib—kidney cancer	4.78e-05	0.000474	CcSEcCtD
Dexamethasone—Asthenia—Dactinomycin—kidney cancer	4.75e-05	0.00047	CcSEcCtD
Dexamethasone—Erythema—Capecitabine—kidney cancer	4.72e-05	0.000468	CcSEcCtD
Dexamethasone—Anaphylactic shock—Paclitaxel—kidney cancer	4.69e-05	0.000465	CcSEcCtD
Dexamethasone—Oedema—Paclitaxel—kidney cancer	4.69e-05	0.000465	CcSEcCtD
Dexamethasone—Abdominal pain—Vincristine—kidney cancer	4.67e-05	0.000463	CcSEcCtD
Dexamethasone—Body temperature increased—Vincristine—kidney cancer	4.67e-05	0.000463	CcSEcCtD
Dexamethasone—Infection—Paclitaxel—kidney cancer	4.66e-05	0.000462	CcSEcCtD
Dexamethasone—Prednisone—ABCB1—kidney cancer	4.65e-05	0.0285	CrCbGaD
Dexamethasone—Dry skin—Doxorubicin—kidney cancer	4.63e-05	0.000459	CcSEcCtD
Dexamethasone—Dizziness—Sunitinib—kidney cancer	4.62e-05	0.000458	CcSEcCtD
Dexamethasone—Feeling abnormal—Gemcitabine—kidney cancer	4.62e-05	0.000458	CcSEcCtD
Dexamethasone—Shock—Paclitaxel—kidney cancer	4.62e-05	0.000458	CcSEcCtD
Dexamethasone—Vomiting—Sorafenib—kidney cancer	4.62e-05	0.000457	CcSEcCtD
Dexamethasone—Nervous system disorder—Paclitaxel—kidney cancer	4.6e-05	0.000456	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—kidney cancer	4.6e-05	0.000456	CcSEcCtD
Dexamethasone—Thrombocytopenia—Paclitaxel—kidney cancer	4.6e-05	0.000455	CcSEcCtD
Dexamethasone—Tachycardia—Paclitaxel—kidney cancer	4.58e-05	0.000454	CcSEcCtD
Dexamethasone—Rash—Sorafenib—kidney cancer	4.58e-05	0.000454	CcSEcCtD
Dexamethasone—Dermatitis—Sorafenib—kidney cancer	4.57e-05	0.000453	CcSEcCtD
Dexamethasone—Headache—Sorafenib—kidney cancer	4.55e-05	0.000451	CcSEcCtD
Dexamethasone—Hyperhidrosis—Paclitaxel—kidney cancer	4.54e-05	0.00045	CcSEcCtD
Dexamethasone—Diarrhoea—Dactinomycin—kidney cancer	4.53e-05	0.000448	CcSEcCtD
Dexamethasone—Anorexia—Paclitaxel—kidney cancer	4.47e-05	0.000443	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—kidney cancer	4.46e-05	0.000441	CcSEcCtD
Dexamethasone—Vomiting—Sunitinib—kidney cancer	4.44e-05	0.00044	CcSEcCtD
Dexamethasone—Body temperature increased—Gemcitabine—kidney cancer	4.43e-05	0.000439	CcSEcCtD
Dexamethasone—Rash—Sunitinib—kidney cancer	4.41e-05	0.000436	CcSEcCtD
Dexamethasone—Dermatitis—Sunitinib—kidney cancer	4.4e-05	0.000436	CcSEcCtD
Dexamethasone—Hypotension—Paclitaxel—kidney cancer	4.39e-05	0.000435	CcSEcCtD
Dexamethasone—Ill-defined disorder—Capecitabine—kidney cancer	4.38e-05	0.000434	CcSEcCtD
Dexamethasone—Headache—Sunitinib—kidney cancer	4.38e-05	0.000434	CcSEcCtD
Dexamethasone—Nausea—Sorafenib—kidney cancer	4.31e-05	0.000427	CcSEcCtD
Dexamethasone—Prednisolone—ABCB1—kidney cancer	4.29e-05	0.0263	CrCbGaD
Dexamethasone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.28e-05	0.000424	CcSEcCtD
Dexamethasone—Malaise—Capecitabine—kidney cancer	4.26e-05	0.000422	CcSEcCtD
Dexamethasone—Insomnia—Paclitaxel—kidney cancer	4.25e-05	0.000421	CcSEcCtD
Dexamethasone—Vertigo—Capecitabine—kidney cancer	4.24e-05	0.00042	CcSEcCtD
Dexamethasone—Asthenia—Vincristine—kidney cancer	4.24e-05	0.00042	CcSEcCtD
Dexamethasone—Syncope—Capecitabine—kidney cancer	4.23e-05	0.000419	CcSEcCtD
Dexamethasone—Paraesthesia—Paclitaxel—kidney cancer	4.22e-05	0.000418	CcSEcCtD
Dexamethasone—Vomiting—Dactinomycin—kidney cancer	4.21e-05	0.000417	CcSEcCtD
Dexamethasone—Betamethasone—ABCB1—kidney cancer	4.2e-05	0.0257	CrCbGaD
Dexamethasone—Rash—Dactinomycin—kidney cancer	4.17e-05	0.000413	CcSEcCtD
Dexamethasone—Nausea—Sunitinib—kidney cancer	4.15e-05	0.000411	CcSEcCtD
Dexamethasone—Loss of consciousness—Capecitabine—kidney cancer	4.15e-05	0.000411	CcSEcCtD
Dexamethasone—Dyspepsia—Paclitaxel—kidney cancer	4.13e-05	0.000409	CcSEcCtD
Dexamethasone—Decreased appetite—Paclitaxel—kidney cancer	4.08e-05	0.000404	CcSEcCtD
Dexamethasone—Hypertension—Capecitabine—kidney cancer	4.08e-05	0.000404	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.05e-05	0.000401	CcSEcCtD
Dexamethasone—Fatigue—Paclitaxel—kidney cancer	4.05e-05	0.000401	CcSEcCtD
Dexamethasone—Diarrhoea—Vincristine—kidney cancer	4.04e-05	0.000401	CcSEcCtD
Dexamethasone—Asthenia—Gemcitabine—kidney cancer	4.02e-05	0.000399	CcSEcCtD
Dexamethasone—Myalgia—Capecitabine—kidney cancer	4.02e-05	0.000398	CcSEcCtD
Dexamethasone—Pain—Paclitaxel—kidney cancer	4.01e-05	0.000398	CcSEcCtD
Dexamethasone—Anxiety—Capecitabine—kidney cancer	4e-05	0.000397	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—kidney cancer	3.97e-05	0.000394	CcSEcCtD
Dexamethasone—Discomfort—Capecitabine—kidney cancer	3.97e-05	0.000393	CcSEcCtD
Dexamethasone—Pruritus—Gemcitabine—kidney cancer	3.97e-05	0.000393	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—kidney cancer	3.95e-05	0.000391	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—kidney cancer	3.94e-05	0.00039	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—kidney cancer	3.93e-05	0.000389	CcSEcCtD
Dexamethasone—Dizziness—Vincristine—kidney cancer	3.91e-05	0.000387	CcSEcCtD
Dexamethasone—Feeling abnormal—Paclitaxel—kidney cancer	3.87e-05	0.000383	CcSEcCtD
Dexamethasone—Oedema—Capecitabine—kidney cancer	3.85e-05	0.000382	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Paclitaxel—kidney cancer	3.84e-05	0.00038	CcSEcCtD
Dexamethasone—Diarrhoea—Gemcitabine—kidney cancer	3.84e-05	0.00038	CcSEcCtD
Dexamethasone—Infection—Capecitabine—kidney cancer	3.83e-05	0.000379	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—kidney cancer	3.82e-05	0.000378	CcSEcCtD
Dexamethasone—Shock—Capecitabine—kidney cancer	3.79e-05	0.000375	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—kidney cancer	3.78e-05	0.000375	CcSEcCtD
Dexamethasone—Nervous system disorder—Capecitabine—kidney cancer	3.78e-05	0.000374	CcSEcCtD
Dexamethasone—Thrombocytopenia—Capecitabine—kidney cancer	3.77e-05	0.000374	CcSEcCtD
Dexamethasone—Tachycardia—Capecitabine—kidney cancer	3.76e-05	0.000372	CcSEcCtD
Dexamethasone—Vomiting—Vincristine—kidney cancer	3.76e-05	0.000372	CcSEcCtD
Dexamethasone—Urticaria—Paclitaxel—kidney cancer	3.73e-05	0.000369	CcSEcCtD
Dexamethasone—Rash—Vincristine—kidney cancer	3.73e-05	0.000369	CcSEcCtD
Dexamethasone—Hyperhidrosis—Capecitabine—kidney cancer	3.72e-05	0.000369	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—kidney cancer	3.72e-05	0.000369	CcSEcCtD
Dexamethasone—Body temperature increased—Paclitaxel—kidney cancer	3.71e-05	0.000368	CcSEcCtD
Dexamethasone—Abdominal pain—Paclitaxel—kidney cancer	3.71e-05	0.000368	CcSEcCtD
Dexamethasone—Headache—Vincristine—kidney cancer	3.7e-05	0.000367	CcSEcCtD
Dexamethasone—Anorexia—Capecitabine—kidney cancer	3.67e-05	0.000364	CcSEcCtD
Dexamethasone—Hypotension—Capecitabine—kidney cancer	3.6e-05	0.000357	CcSEcCtD
Dexamethasone—Vomiting—Gemcitabine—kidney cancer	3.56e-05	0.000353	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—kidney cancer	3.56e-05	0.000352	CcSEcCtD
Dexamethasone—Rash—Gemcitabine—kidney cancer	3.54e-05	0.00035	CcSEcCtD
Dexamethasone—Dermatitis—Gemcitabine—kidney cancer	3.53e-05	0.00035	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—kidney cancer	3.51e-05	0.000348	CcSEcCtD
Dexamethasone—Headache—Gemcitabine—kidney cancer	3.51e-05	0.000348	CcSEcCtD
Dexamethasone—Nausea—Vincristine—kidney cancer	3.51e-05	0.000348	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.51e-05	0.000348	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—kidney cancer	3.5e-05	0.000346	CcSEcCtD
Dexamethasone—Insomnia—Capecitabine—kidney cancer	3.48e-05	0.000345	CcSEcCtD
Dexamethasone—Paraesthesia—Capecitabine—kidney cancer	3.46e-05	0.000343	CcSEcCtD
Dexamethasone—Dyspepsia—Capecitabine—kidney cancer	3.39e-05	0.000336	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—kidney cancer	3.37e-05	0.000334	CcSEcCtD
Dexamethasone—Asthenia—Paclitaxel—kidney cancer	3.37e-05	0.000334	CcSEcCtD
Dexamethasone—Decreased appetite—Capecitabine—kidney cancer	3.35e-05	0.000332	CcSEcCtD
Dexamethasone—Nausea—Gemcitabine—kidney cancer	3.33e-05	0.00033	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Capecitabine—kidney cancer	3.33e-05	0.000329	CcSEcCtD
Dexamethasone—Fatigue—Capecitabine—kidney cancer	3.32e-05	0.000329	CcSEcCtD
Dexamethasone—Pruritus—Paclitaxel—kidney cancer	3.32e-05	0.000329	CcSEcCtD
Dexamethasone—Pain—Capecitabine—kidney cancer	3.29e-05	0.000326	CcSEcCtD
Dexamethasone—Hydrocortisone—ABCB1—kidney cancer	3.28e-05	0.0201	CrCbGaD
Dexamethasone—Eye disorder—Doxorubicin—kidney cancer	3.27e-05	0.000324	CcSEcCtD
Dexamethasone—Diarrhoea—Paclitaxel—kidney cancer	3.21e-05	0.000318	CcSEcCtD
Dexamethasone—Feeling abnormal—Capecitabine—kidney cancer	3.17e-05	0.000314	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—kidney cancer	3.17e-05	0.000314	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Capecitabine—kidney cancer	3.15e-05	0.000312	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—kidney cancer	3.12e-05	0.000309	CcSEcCtD
Dexamethasone—Dizziness—Paclitaxel—kidney cancer	3.1e-05	0.000308	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—kidney cancer	3.09e-05	0.000306	CcSEcCtD
Dexamethasone—Urticaria—Capecitabine—kidney cancer	3.06e-05	0.000303	CcSEcCtD
Dexamethasone—Abdominal pain—Capecitabine—kidney cancer	3.05e-05	0.000302	CcSEcCtD
Dexamethasone—Body temperature increased—Capecitabine—kidney cancer	3.05e-05	0.000302	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—kidney cancer	3.04e-05	0.000301	CcSEcCtD
Dexamethasone—Vomiting—Paclitaxel—kidney cancer	2.98e-05	0.000296	CcSEcCtD
Dexamethasone—Rash—Paclitaxel—kidney cancer	2.96e-05	0.000293	CcSEcCtD
Dexamethasone—Dermatitis—Paclitaxel—kidney cancer	2.96e-05	0.000293	CcSEcCtD
Dexamethasone—Headache—Paclitaxel—kidney cancer	2.94e-05	0.000291	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—kidney cancer	2.82e-05	0.00028	CcSEcCtD
Dexamethasone—Nausea—Paclitaxel—kidney cancer	2.79e-05	0.000276	CcSEcCtD
Dexamethasone—Asthenia—Capecitabine—kidney cancer	2.76e-05	0.000274	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—kidney cancer	2.74e-05	0.000272	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—kidney cancer	2.73e-05	0.000271	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—kidney cancer	2.73e-05	0.00027	CcSEcCtD
Dexamethasone—Pruritus—Capecitabine—kidney cancer	2.73e-05	0.00027	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—kidney cancer	2.67e-05	0.000265	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—kidney cancer	2.64e-05	0.000261	CcSEcCtD
Dexamethasone—Diarrhoea—Capecitabine—kidney cancer	2.64e-05	0.000261	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—kidney cancer	2.63e-05	0.00026	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—kidney cancer	2.59e-05	0.000257	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—kidney cancer	2.58e-05	0.000256	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—kidney cancer	2.56e-05	0.000254	CcSEcCtD
Dexamethasone—Dizziness—Capecitabine—kidney cancer	2.55e-05	0.000252	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—kidney cancer	2.48e-05	0.000246	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—kidney cancer	2.48e-05	0.000246	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—kidney cancer	2.47e-05	0.000244	CcSEcCtD
Dexamethasone—Vomiting—Capecitabine—kidney cancer	2.45e-05	0.000243	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—kidney cancer	2.44e-05	0.000242	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—kidney cancer	2.44e-05	0.000241	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—kidney cancer	2.43e-05	0.000241	CcSEcCtD
Dexamethasone—Rash—Capecitabine—kidney cancer	2.43e-05	0.000241	CcSEcCtD
Dexamethasone—Dermatitis—Capecitabine—kidney cancer	2.43e-05	0.00024	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—kidney cancer	2.42e-05	0.00024	CcSEcCtD
Dexamethasone—Headache—Capecitabine—kidney cancer	2.41e-05	0.000239	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—kidney cancer	2.4e-05	0.000238	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—kidney cancer	2.37e-05	0.000234	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—kidney cancer	2.32e-05	0.00023	CcSEcCtD
Dexamethasone—Nausea—Capecitabine—kidney cancer	2.29e-05	0.000227	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.26e-05	0.000224	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—kidney cancer	2.25e-05	0.000222	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—kidney cancer	2.23e-05	0.000221	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—kidney cancer	2.19e-05	0.000217	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—kidney cancer	2.16e-05	0.000214	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.14e-05	0.000212	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—kidney cancer	2.14e-05	0.000212	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—kidney cancer	2.12e-05	0.00021	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—kidney cancer	2.05e-05	0.000203	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—kidney cancer	2.03e-05	0.000201	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—kidney cancer	1.97e-05	0.000195	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—kidney cancer	1.96e-05	0.000194	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—kidney cancer	1.96e-05	0.000194	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—kidney cancer	1.78e-05	0.000176	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—kidney cancer	1.76e-05	0.000174	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—kidney cancer	1.7e-05	0.000168	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—kidney cancer	1.64e-05	0.000163	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—kidney cancer	1.58e-05	0.000156	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—kidney cancer	1.57e-05	0.000155	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—kidney cancer	1.56e-05	0.000155	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—kidney cancer	1.56e-05	0.000154	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—kidney cancer	1.48e-05	0.000146	CcSEcCtD
Dexamethasone—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.99e-06	4.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ITPR2—kidney cancer	2.98e-06	4.36e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP1A1—kidney cancer	2.97e-06	4.34e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CRABP1—kidney cancer	2.95e-06	4.32e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MAPK3—kidney cancer	2.94e-06	4.31e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP1A1—kidney cancer	2.94e-06	4.3e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.93e-06	4.29e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ABCB1—kidney cancer	2.93e-06	4.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CRABP1—kidney cancer	2.93e-06	4.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.92e-06	4.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALAD—kidney cancer	2.92e-06	4.27e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ITPR2—kidney cancer	2.91e-06	4.26e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTEN—kidney cancer	2.9e-06	4.24e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—BCHE—kidney cancer	2.9e-06	4.24e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PIK3CA—kidney cancer	2.89e-06	4.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SCARB1—kidney cancer	2.89e-06	4.22e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—kidney cancer	2.86e-06	4.19e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC5A5—kidney cancer	2.86e-06	4.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS1—kidney cancer	2.86e-06	4.18e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.85e-06	4.17e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GSTM1—kidney cancer	2.84e-06	4.16e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PSMD7—kidney cancer	2.8e-06	4.1e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—kidney cancer	2.79e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—POMC—kidney cancer	2.79e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.78e-06	4.07e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.78e-06	4.07e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC2A1—kidney cancer	2.76e-06	4.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.75e-06	4.02e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ITPR2—kidney cancer	2.74e-06	4.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ACHE—kidney cancer	2.72e-06	3.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTT1—kidney cancer	2.72e-06	3.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ITPR2—kidney cancer	2.72e-06	3.98e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CYP1A1—kidney cancer	2.69e-06	3.94e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.68e-06	3.92e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.68e-06	3.92e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PIK3CA—kidney cancer	2.67e-06	3.91e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PGK1—kidney cancer	2.67e-06	3.9e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.67e-06	3.9e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—kidney cancer	2.67e-06	3.9e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTT1—kidney cancer	2.66e-06	3.88e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ACHE—kidney cancer	2.66e-06	3.88e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—BCHE—kidney cancer	2.66e-06	3.88e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RAF1—kidney cancer	2.65e-06	3.88e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTEN—kidney cancer	2.65e-06	3.88e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RELA—kidney cancer	2.64e-06	3.87e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.63e-06	3.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ERBB2—kidney cancer	2.63e-06	3.84e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTEN—kidney cancer	2.62e-06	3.84e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.62e-06	3.84e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LDHB—kidney cancer	2.62e-06	3.83e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GSTP1—kidney cancer	2.6e-06	3.8e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MTOR—kidney cancer	2.59e-06	3.79e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SCARB1—kidney cancer	2.58e-06	3.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS1—kidney cancer	2.55e-06	3.73e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.53e-06	3.71e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—POMC—kidney cancer	2.52e-06	3.69e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SCARB1—kidney cancer	2.51e-06	3.68e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.51e-06	3.67e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTT1—kidney cancer	2.5e-06	3.66e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ACHE—kidney cancer	2.5e-06	3.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PSMD7—kidney cancer	2.5e-06	3.66e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GSTP1—kidney cancer	2.5e-06	3.65e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS1—kidney cancer	2.49e-06	3.64e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTT1—kidney cancer	2.48e-06	3.63e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ACHE—kidney cancer	2.48e-06	3.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ABCB1—kidney cancer	2.46e-06	3.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.46e-06	3.6e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSTP1—kidney cancer	2.44e-06	3.58e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PSMD7—kidney cancer	2.44e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSTP1—kidney cancer	2.44e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CDKN1B—kidney cancer	2.43e-06	3.56e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—POMC—kidney cancer	2.43e-06	3.56e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HIF1A—kidney cancer	2.4e-06	3.51e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TSC2—kidney cancer	2.4e-06	3.5e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GSTM1—kidney cancer	2.39e-06	3.49e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL2—kidney cancer	2.38e-06	3.48e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—BCHE—kidney cancer	2.37e-06	3.47e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SCARB1—kidney cancer	2.37e-06	3.47e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ABCB1—kidney cancer	2.36e-06	3.46e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SCARB1—kidney cancer	2.35e-06	3.44e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS1—kidney cancer	2.34e-06	3.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.34e-06	3.42e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.34e-06	3.42e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTEN—kidney cancer	2.33e-06	3.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS1—kidney cancer	2.32e-06	3.4e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—kidney cancer	2.32e-06	3.39e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—JUN—kidney cancer	2.31e-06	3.39e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ABCB1—kidney cancer	2.31e-06	3.38e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—BCHE—kidney cancer	2.31e-06	3.38e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ABCB1—kidney cancer	2.31e-06	3.38e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTP1—kidney cancer	2.3e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PSMD7—kidney cancer	2.3e-06	3.36e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—kidney cancer	2.3e-06	3.36e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GSTM1—kidney cancer	2.29e-06	3.35e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC5A5—kidney cancer	2.28e-06	3.34e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PSMD7—kidney cancer	2.28e-06	3.34e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CA9—kidney cancer	2.27e-06	3.32e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CYP1A1—kidney cancer	2.26e-06	3.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.26e-06	3.31e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSTM1—kidney cancer	2.25e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSTM1—kidney cancer	2.24e-06	3.28e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTEN—kidney cancer	2.24e-06	3.28e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—kidney cancer	2.23e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—POMC—kidney cancer	2.21e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC2A1—kidney cancer	2.21e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.19e-06	3.21e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—POMC—kidney cancer	2.19e-06	3.21e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ABCB1—kidney cancer	2.18e-06	3.19e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—BCHE—kidney cancer	2.18e-06	3.19e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.17e-06	3.18e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—BCHE—kidney cancer	2.16e-06	3.16e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC5A5—kidney cancer	2.15e-06	3.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.14e-06	3.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.13e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP1A1—kidney cancer	2.13e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.12e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTM1—kidney cancer	2.12e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—kidney cancer	2.12e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APC—kidney cancer	2.12e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTP1—kidney cancer	2.11e-06	3.09e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.1e-06	3.08e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC2A1—kidney cancer	2.08e-06	3.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.06e-06	3.02e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—kidney cancer	2.04e-06	2.99e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—kidney cancer	2.02e-06	2.96e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—kidney cancer	2.01e-06	2.95e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—POMC—kidney cancer	2.01e-06	2.94e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ABCB1—kidney cancer	2e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BRAF—kidney cancer	1.99e-06	2.91e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—kidney cancer	1.94e-06	2.84e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTM1—kidney cancer	1.94e-06	2.84e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—kidney cancer	1.94e-06	2.84e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CRABP1—kidney cancer	1.93e-06	2.82e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK3—kidney cancer	1.91e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.91e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTP1—kidney cancer	1.89e-06	2.76e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—kidney cancer	1.87e-06	2.74e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—kidney cancer	1.86e-06	2.72e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.86e-06	2.72e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—kidney cancer	1.85e-06	2.71e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—kidney cancer	1.84e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.84e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK1—kidney cancer	1.82e-06	2.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ITPR2—kidney cancer	1.79e-06	2.62e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCB1—kidney cancer	1.78e-06	2.61e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—kidney cancer	1.76e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—kidney cancer	1.76e-06	2.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—kidney cancer	1.75e-06	2.56e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.74e-06	2.55e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—kidney cancer	1.73e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—kidney cancer	1.73e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—kidney cancer	1.72e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—kidney cancer	1.72e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—kidney cancer	1.7e-06	2.49e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—kidney cancer	1.69e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—kidney cancer	1.69e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—POMC—kidney cancer	1.69e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RAF1—kidney cancer	1.66e-06	2.43e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—kidney cancer	1.65e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.65e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.64e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—kidney cancer	1.64e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—kidney cancer	1.64e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—kidney cancer	1.64e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—kidney cancer	1.64e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ACHE—kidney cancer	1.64e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—kidney cancer	1.63e-06	2.38e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTOR—kidney cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—POMC—kidney cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—kidney cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP1A1—kidney cancer	1.6e-06	2.35e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—kidney cancer	1.6e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—kidney cancer	1.59e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—POMC—kidney cancer	1.59e-06	2.32e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—POMC—kidney cancer	1.58e-06	2.32e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—kidney cancer	1.58e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—kidney cancer	1.58e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SCARB1—kidney cancer	1.55e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—kidney cancer	1.54e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS1—kidney cancer	1.53e-06	2.24e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—kidney cancer	1.53e-06	2.24e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—kidney cancer	1.52e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—kidney cancer	1.52e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.51e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.51e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PSMD7—kidney cancer	1.5e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.5e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—POMC—kidney cancer	1.5e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—kidney cancer	1.44e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—BCHE—kidney cancer	1.43e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.41e-06	2.06e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—kidney cancer	1.4e-06	2.05e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—kidney cancer	1.4e-06	2.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—POMC—kidney cancer	1.37e-06	2.01e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—kidney cancer	1.37e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.36e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.35e-06	1.97e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—kidney cancer	1.29e-06	1.89e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—kidney cancer	1.27e-06	1.85e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—kidney cancer	1.26e-06	1.85e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—kidney cancer	1.24e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.23e-06	1.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—POMC—kidney cancer	1.22e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—kidney cancer	1.2e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—POMC—kidney cancer	1.2e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—kidney cancer	1.19e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—kidney cancer	1.19e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—kidney cancer	1.17e-06	1.72e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—kidney cancer	1.16e-06	1.7e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK1—kidney cancer	1.14e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—kidney cancer	1.13e-06	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—kidney cancer	1.13e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—POMC—kidney cancer	1.13e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—POMC—kidney cancer	1.12e-06	1.63e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—kidney cancer	1.1e-06	1.62e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—kidney cancer	1.1e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—kidney cancer	1.09e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—kidney cancer	1.09e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—kidney cancer	1.08e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.08e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—kidney cancer	1.07e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—kidney cancer	1.04e-06	1.52e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—kidney cancer	1.04e-06	1.52e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—kidney cancer	9.88e-07	1.45e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.88e-07	1.45e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—kidney cancer	9.86e-07	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—kidney cancer	9.77e-07	1.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—kidney cancer	9.54e-07	1.4e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—kidney cancer	9.53e-07	1.4e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—kidney cancer	8.99e-07	1.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—kidney cancer	8.91e-07	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—kidney cancer	8.52e-07	1.25e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—kidney cancer	8.32e-07	1.22e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—kidney cancer	8.28e-07	1.21e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—kidney cancer	7.95e-07	1.16e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—kidney cancer	7.84e-07	1.15e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—kidney cancer	7.79e-07	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—kidney cancer	7.77e-07	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—kidney cancer	7.77e-07	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—POMC—kidney cancer	7.37e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—kidney cancer	7.34e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—kidney cancer	6.73e-07	9.85e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—kidney cancer	6.01e-07	8.79e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—kidney cancer	5.87e-07	8.59e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—kidney cancer	5.87e-07	8.58e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—kidney cancer	5.53e-07	8.09e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—kidney cancer	5.48e-07	8.02e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—kidney cancer	5.12e-07	7.5e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.61e-07	5.29e-06	CbGpPWpGaD
